Dr. Bomdica Nagarjun Reddy

Dr. Bomdica Nagarjun Reddy
Radiation Oncologist, Hyderabad

MBBS, MD

  • 1 Hospital
  • Asst. Professor of Radiotherapy Osmania Medical College / MNJ Institute of Oncology    & Regional Cancer Center Red Hills, Hyderabad , A.P
  • Associate Professor of Radiotherapy S.V. Medical College , Tirupati, Andhra Pradesh
  • Professor of Radiotherapy Osmania Medical College / MNJ Institute of Oncology &    Regional Cancer Center Red Hills, Hyderabad

Specialities

  • Radiation Oncology

Expertise

Education

  • MBBS from Osmania Medical College Osmania University,Hyderabad, 1978
  • MD(RAdiotherapy) from OMC, Hyderabad, 1984

Practice Information

MNJ Institute of Oncology & Regional Cancer Centre, Hyderabad

MNJ Institute of Oncology & Regional Cancer Centre, Hyderabad

Red Hills, Lakdi Ka Pool, Hyderabad, Telangana - 500004

Patient Experience

Your participation in the survey will help other patients make informed decisions. You will also be helping Dr. Bomdica Nagarjun Reddy and his staff know how they are doing and how they can improve their services.

Achievements & Contributions

  • Participation in scientific meetings :Technology transfer program on Lymphomas and Leukemia organized by WHO in February 1986 at Bangalore and Madras .
  • Indo-British Collaboration workshop on Radiation Oncology in December 1988 at Ahmedabad, Gujarat Cancer     Centre. 
  • Indo-Japanese Symposium on Radio Modifiers in management of Cancer in February 1992 held at Kidwai     Memorial Cancer Centre, Bangalore . 
  • Attended Annual Congress of Radiation Oncologists of India held annually at different places. 
  • Organized CME and XIV annual National Congress of Association of Radiation Oncology held at MNJIO&RCC,     Hyderabad on 27-30 January 1993 
  • UICC - 1994
  • Clinical TrialsCo-Investigator : Protocol H3E-AAS037 (a) open label single arm phase II study of ALIMTA in patients with advanced NSCLC / Eli-Lilly. 
  • Droloxifine study in Breast cancer - PFIZER Study. 
  • D6997C00003 9238IL / 0065 Faslodex study in Ca. Breast - Spectra Clinical Research Group. 
  • XMO1-21, XMO1-22, XMO23 - Biogeneric study.
  • Member of Association of Radiation Oncologists of India. 
  • Member of Indian Medical Association. 
  • Member of Indian Society of Oncology.